| ils | ~Pa e No | ||||
| Foreword . | |||||
| Statement ofTrustee Responsibilities | . | ||||
| Trustee Report . | |||||
| Trustee Report Appendices | 15 | ||||
| Appendix A - Schedule of |
Charitable | Funds | |||
| Appendix B - Donated Income Policy | |||||
| Appendix C - Investment |
Guidelines | ||||
| Appendix D - Invested Pool Guidelines |
for Restricted Funds | ||||
| Appendix E - Reserves policy | |||||
| Appendix F - General Purpose Guidelines | |||||
| Financial Statements 2020/21 |
25 | ||||
| Statement ofFinancial Activities . | 26 | ||||
| Balance Sheet . | 27 | ||||
| Cash flow Report . | 28 | ||||
| Notes to the Accounts | 29 | ||||
| Auditor's Opinion . |
43 |
| 2020-21 | 2020-21 | 2020-21 | 2020-21 | 2019-20 | 2019-20 | 2019-20 | 2019-20 | ||
|---|---|---|---|---|---|---|---|---|---|
| Note | Unrestricted Funds |
Restricted Funds |
Endowment Funds |
Total Funds | Unrestricted Funds |
Restricted Funds |
Endowment Funds |
Total Funds | |
| f000 | 8000 | 1000 | fooo | f000 | 5000 | 4000 | f000 | ||
| Income snd | |||||||||
| Endowments from: |
|||||||||
| Donations dt Legacies |
2.1 | 0 | 1,446 | 0 | 1,446 | 0 | 2,440 | 0 | 2,440 |
| Other Trading activities | 2.2 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 4 |
| Investments | 23 | 0 | 247 | 0 | 247 | 0 | 290 | 0 | 290 |
| Total Income dr Endowments | 0 | 1,693 | 0 | 1,693 | 0 | 2,734 | 0 | 2,734 | |
| Expenditure on: |
|||||||||
| Raising funds | 3 | 0 | 357 | 0 | 357 | 0 | 403 | 0 | 403 |
| Charitable activities |
4 | 0 | 1,134 | 0 | 1,134 | 0 | 3,187 | 0 | 3,187 |
| Governance | 5 | 0 | 52 | 0 | 52 | 0 | 46 | 0 | 46 |
| Total Expenditure | 0 | 1,543 | 0 | 1,543 | 0 | 3,636 | 0 | 3,636 | |
| Net Gains / (Losses) on Investments |
8 | 0 | 1,714 | (I) | 1,713 | 0 | (1,150) | (I) | (1,151) |
| Net Income / (Expenditure) |
1,864 | (I) | 1,863 | 0 | (2,052) | (I) | (2,053) | ||
| Transfers between funds |
0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net movement in funds |
6 | 0 | 1,864 | (I) | 1,863 | 0 | (2,052) | (I) | (2,053) |
| Reconciliation offunds: |
|||||||||
| Fund balances carried forward at MARCH 2020 |
31 | 6,385 | 80 | 6,465 | 0 | 8,437 | 81 | 8,518 | |
| Fund balances carried forward MARCH 2021 |
at 31 | 8,249 | 79 | 8328 | 0 | 6885 | 80 | 6,465 | |
| The notes at pages 29 to 42 form | part ofthese financial | statements. |
| Unrestricted | Restricted | Endowment | Total at | Urlrcstrlcted | Restncted | Endowment | Total at | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Notes | Funds | Funds | Funds | 31March | Funds | Funds | Funds | 31March | |||||
| 31.03.21 | 31.03.21 | 31.03.21 | 2021 | 31.0320 | 31.03.20 | 310320 | 2020 | ||||||
| fOOD | f000 | f000 | f000 | fsss | 8000 | 8000 | foas | ||||||
| Fixed assets: | |||||||||||||
| Investments | 8 | 0 | 8,911 | 79 | 8,990 | 0 | 7,705 | 80 | 7,785 | ||||
| Total Fixed Assets | 0 | 8,911 | 79 | 8,990 | 0 | 7,705 | 80 | 7,785 | |||||
| Current assets: | |||||||||||||
| Stocks | 0 | 6 | |||||||||||
| Debtors | 10 | 153 | 153 | 178 | 0 | 178 | |||||||
| Cash at bank | and in hand | 1,396 | 1,396 | 1,539 | 0 | 1,539 | |||||||
| Total Current Assets | 0 | 1,554 | 0 | 1,554 | 0 | 1,723 | 0 | 1,723 | |||||
| Creditors: Amounts falling due within one year |
11.1 | 0 | 1,335 | 0 | I/35 | 0 | 2,237 | 0 | 2,237 | ||||
| Net Current Assets | / | (Liabilities) | 0 | 219 | 0 | 219 | 0 | (514) | 0 | (514) | |||
| Total Assets less Current | Liabilities | 0 | 9,130 | 79 | 9,209 | 0 | 7,191 | 80 | 7,271 | ||||
| Creditors: Amounts than one year |
falling | due after more | I1.2 | 0 | 881 | 0 | 881 | 0 | 806 | 0 | 806 | ||
| Total Net Assets | 0 | 8,249 | 79 | 8,328 | 0 | 6,385 | 80 | 6,465 | |||||
| Funds ofthe Charity | |||||||||||||
| Capital Funds: | |||||||||||||
| Endowment | funds | 121 | 0 | 79 | 79 | 0 | 0 | 80 | 80 | ||||
| Income Funds; | |||||||||||||
| Restncted | income | funds | 125 | 0 | 8,249 | 0 | 8,249 | 0 | 6,385 | 0 | 6,385 | ||
| Unrestricted | funds | 0 | 0 | 0 | |||||||||
| Total charity funds | 0 | 8,249 | 79 | 8,328 | 0 | 6,385 | 80 | 6,465 |
| Total | Total | |||||
|---|---|---|---|---|---|---|
| 2020/21 | 2019/20 | |||||
| 5000 | OOOO | |||||
| Cash flows from Operating Activities: |
||||||
| Net Cash | provided by (used in) operating |
activities | ~898 | ~238 | ||
| Cash flows from investing activities: |
||||||
| Returns on Investments |
247 | 290 | ||||
| Proceeds | from sale ofinvestments | 3,737 | 4,568 | |||
| Purchase | ofInvestments | (3,229) | (4,317) | |||
| Net cash | provided by (used in) investing |
activities | 755 | 541 | ||
| Change in cash and cash equivalents | (143) | 303 | ||||
| Cash and | Cash equivalents at the start of |
the year | 1,539 | 1,236 | ||
| Cash and | Cash equivalents at the end ofthe year |
1,396 | 1,539 | |||
| ReconciTiation ofnet income / (expenditure) |
to net cash flow from Operating | activities | ||||
| Net income / (expenditure) as per the SOFA |
1,863 | (2,053) | ||||
| Dividends | and Interest from Investments | (247) | (290) | |||
| (Increase) | / decrease in Stocks | |||||
| (Increase) | / decrease in Debtors | 25 | (51) | |||
| Increase/ | (decrease) in Creditors | (827) | 1,005 | |||
| (Increase) | / decrease in Investment Gains / Losses |
(1,713) | 1,151 | |||
| Net cash | (outflow) / inflow from operating |
activities | (898) | (238) |
| S Musson | Chair |
|---|---|
| M Eastwood | Non Executive Director |
| D Fillingham | Non Executive Director (to 30th July 2020) |
| I Ismail | Non Executive Director (from 1st September 2021) |
| TJohnston | Non Executive Director |
| Prof L Kenny | Non Executive Director (to 30th June 2021) |
| A Phillips | Non Executive Director (to 30th September 2020) |
| S Samuels | Non Executive Director (from 1st September 2020) |
| Ede Souse | Non Executive Director (from 1st September 2020) |
| ProfTWalley | Non Executive Director (froml st July 2021) |
| M Weame | Non Executive Director (to 31st August 2021) |
| N Willcox | Non Executive Director |
| S Warbuton | Chief Executive Ofticer (to 5th September 2021) |
| D Dalton | Interim Chief Executive Officer (from 6th September 2021) |
| D Brown | Chief Nurse (to 3rd October 2021) |
| E Ingtesby-Burke | Interim Chief Nurse (from 4th October 2021) |
| TCope | Medical Director (to 17th October 2021) |
| J Brennan | Interim Medical Director (fiom 18th October 2021) |
| R Forster | Deputy Chief Executive Oflicer &Chief Finance Offiver |
| D Herring | Chief People OAicer |
| BWeston | Chief Operating Officer |
| Donations | dt | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Legacies | 2.1 | ||||||||||||
| Unrestricted 2020-21 Funds |
Restricted 2020-21 Funds |
Endowment 2020-21 Funds |
Total 2020-21 Funds |
Total 2019-20 Funds |
|||||||||
| f000 | f000 | f000 | f000 | fooc | |||||||||
| Donations | 1,313 | 1,313 | 1,897 | ||||||||||
| Legacies | 133 | 133 | 543 | ||||||||||
| Total | 0 | 1,446 | 0 | 1,446 | 2,440 | ||||||||
| Trading | |||||||||||||
| Activities | 2.2 | ||||||||||||
| Unrestricted 2020-21 |
Restricted 2020-21 |
Endowment 2020-21 |
Total 2020-21 |
Total 2019-20 Funds |
|||||||||
| Funds | Funds | Funds | Funds | ||||||||||
| 5000 | fsgs | f000 | 1000 | f000 | |||||||||
| Fundiaising | |||||||||||||
| Total | 0 | 0 | 0 | 0 | 4 | ||||||||
| Investment | |||||||||||||
| Income | 2.3 | ||||||||||||
| Unrestricted 2020-21 |
Restricted 2020-21 |
Endowment 2020-21 |
Total 2020-21 |
Total 2019-20Funds |
|||||||||
| Funds | Funds | Funds | Funds | ||||||||||
| f000 | 8000 | 8000 | 8000 | 8000 | |||||||||
| Dividends | and investment | Interest | 247 | 247 | 281 | ||||||||
| Bank Interest | |||||||||||||
| Total | 0 | 247 | 0 | 247 | 290 | ||||||||
| Expenditure | on | ||||||||||||
| Raising funds | |||||||||||||
| Unrestricted 2020-21 Funds |
Restricted 2020-21 Funds |
Endowment 2020-21 Funds |
Total 2020-21 Funds |
Total 2019-20Funds |
|||||||||
| f000 | 5000 | fees | f000 | f000 | |||||||||
| Fundraising | Costs | 305 | 305 | 348 | |||||||||
| Investment | Management | 52 | 52 | 55 | |||||||||
| Total | 0 | 357 | 0 | 357 | 403 | ||||||||
| Expenditure | on | ||||||||||||
| Charitable | |||||||||||||
| Activities | 4 | ||||||||||||
| Unrestricted | Restricted | Endowment | Total | ||||||||||
| 2020-21 | 2020-21 | 2020-21 | 2020-21 | Total 2019-20 Funds |
|||||||||
| Funds | Funds | Funds | Funds | ||||||||||
| f000 | f000 | 5000 | 8000 | f000 | |||||||||
| Patients Welfare gi amenities | 77 | 77 | 447 | ||||||||||
| Staff Welfare | &amenities | 733 | 733 | 390 | |||||||||
| Research | di Education | 249 | 249 | 733 | |||||||||
| Contrihuiions | to NHS Capital | 75 | 75 | 1,617 | |||||||||
| Total | 0 | 1,134 | 0 | 1,134 | 3,187 |
| Other | ||||||||
|---|---|---|---|---|---|---|---|---|
| Unrestricted 2020-21 Funds |
Restricted 2020-21 Funds |
Endowment 2020-21 Funds |
Total 2020-21 Funds |
Total 2019-20 Funds |
||||
| 5000 | 5000 | 5000 | 8000 | 1000 | ||||
| Governance | 52 | 52 | 46 | |||||
| Total | 52 | |||||||
| Allocation | and | |||||||
| Apportion Governance |
to | Basisof Allocation |
Allocated to Governance |
Residual for Apportion |
Total 2020-21 Funds |
Total 2019-20 Funds |
||
| Costs | ||||||||
| f000 | 5000 | 5000 | fOOO | |||||
| Salanes | Time Spent | 28 | 63 | 91 | 99 | |||
| Establishment | Costs | Governance | ||||||
| Audit Fee | Governance | 10 | ||||||
| Misceganeous | Governance | 12 | 13 | |||||
| Total | 52 | 64 | 116 | 116 |
| Apportion | of | Support | Total costs | Total costs | |||||
|---|---|---|---|---|---|---|---|---|---|
| Support Costs | s.l | 5000 | Costs f000 |
2020-21 5000 |
2019-20 f000 |
||||
| Expendiuuu on raising Funds: |
|||||||||
| Fundraising | 291 | 14 | 305 | 348 | |||||
| Investment Management |
39 | 13 | 52 | 55 | |||||
| Sub - Total | 330 | 27 | 357 | ||||||
| Expenditure on Charitable |
Activities: | ||||||||
| Patients Welfare & | amenities | 74 | 77 | 447 | |||||
| Staff Welfare | &,amenities | 709 | 24 | 733 | 390 | ||||
| Research | 241 | 249 | 733 | ||||||
| Contnbutions | to NHS Capital | 73 | 75 | 1,617 | |||||
| Sub - Total | 1,097 | 37 | 1,134 | 3,187 | |||||
| Governance | 52 | 52 | 46 | ||||||
| Total Expenditure | 1,427 | 116 | 1,543 | 3,636 |
| Charity | Grants to | Grants to | Support | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Activities | by | Institutions | individuals | Costs 2020- | Total | Total | |||||||||
| Type | 5.3 | 2020-21 | 2020-21 | 21 | 2020-21 | 2019-20 | |||||||||
| f000 | f000 | 8000 | 8000 | f000 | |||||||||||
| Patients Welfare | k amenities | 74 | 77 | 447 | |||||||||||
| Staff Welfare | k | amenities | 450 | 259 | 24 | 733 | 390 | ||||||||
| Research | 241 | 249 | 733 | ||||||||||||
| Contributions | to | NHS | Capital | 73 | 75 | 1,617 | |||||||||
| Total | 838 | 259 | 37 | 1,134 | 3,187 | ||||||||||
| Grants | |||||||||||||||
| awarded | to | Total | Total | ||||||||||||
| insitutions | 5.4 | 2020-21 | 2019-20 | ||||||||||||
| 8000 | f000 | ||||||||||||||
| Liverpool | Univemity | Hospital | NHS FT/ | ||||||||||||
| Royal Liverpool | k Broadgreen | University | 794 | 2,941 | |||||||||||
| Hospitals | NHS | Trust | |||||||||||||
| University | of | Liverpool | 44 | 185 | |||||||||||
| 838 | 3,126 | ||||||||||||||
| Changes | in | ||||||||||||||
| Resources | Restricted | Endowment | Total | Total | |||||||||||
| Available | for | Unrestricted | 2020-21 | 2020-21 | 2020-21 | 2019-20 | |||||||||
| Charity | Use | 6 | 2020-21 Funds | Funds | Funds | Funds | Funds | ||||||||
| 8000 | 8000 | 8000 | f000 | f000 | |||||||||||
| Net movement | in funds for the | year | 1,864 | 1,863 | (2,053) | ||||||||||
| Net movement | in tangible | frxixt assets | |||||||||||||
| Net movement | in funds available | ||||||||||||||
| 0 | 1,864 | (1) | 1,863 | (2,053) |
| 2020-21 | 2019-20 | |||||
|---|---|---|---|---|---|---|
| 8.1 | Fixed Asset Investments: | 8000 | 5000 | |||
| Market value at | 31 March 2020 | 7,785 | 9,187 | |||
| Less: Disposals | at carrying value | (3,737) | (4,568) | |||
| Add: Acquisitions at cost |
3,Z29 | 4,317 | ||||
| Net gain on revaluation | 1,713 | (1,151) | ||||
| Market value at | 31 March 2021 | 8,990 | 7,785 | |||
| Historic cost at | 31March 2021 | 7,898 | 8,407 | |||
| Held in | Held outside | 2020-21 | 2019-20 | |||
| 8.2 | Market value at | 31 March: | UK | UK | Total | Total |
| f.000 | f000 | 8000 | 5000 | |||
| Investments listed on the Stock Exchange |
8,878 | 8,878 | 7,505 | |||
| Cash held as part ofthe investment | 112 | 112 | 280 | |||
| portfolio | ||||||
| 8,990 | 8,990 | 7,785 |
| Total as at | Total as at 31 | ||||||
|---|---|---|---|---|---|---|---|
| Analysis | of | 10 | 31 MARCH | MARCH | |||
| Debtors | 2021 | 2020 | |||||
| 10.1 | Amounts | falling due within one year: | 8000 | f000 | |||
| Prepayments | |||||||
| Accrued income | 151 | 178 | |||||
| Total debtors falling due within one year | 153 | 178 | |||||
| 10.2 | Amounts | falling due over one year: | |||||
| Total debtors falling due after more than one year | |||||||
| Total debtors | 153 | 178 | |||||
| Total as at | Total as at 31 | ||||||
| Analysis | of | 31MARCH | MARCH | ||||
| Creditors | 2021 | 2020 | |||||
| 11.1 | Amounts | falling due within one year: | 8000 | f000 | |||
| Other creditors | 152 | 302 | |||||
| Accruals | 1,183 | 1,935 | |||||
| Deferred income | |||||||
| Total creditors | falling due within one year | 1,335 | 2,237 | ||||
| 11.2 | Amounts | falling due atter more than one year: | |||||
| Accruals | 881 | 806 | |||||
| Total creditors | falling after more than one year | 881 | |||||
| Total creditors | 2,216 | 3,043 |
| Analysis of | 12 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Funds | |||||||||||
| 12,1 | Endowment | Funds 31.03.21 | Balance 31 March 2020 |
Incoming Resources |
Resources Expended |
Transfers | Gains and Losses |
Balance 31 March 2021 |
|||
| (list | individually) | f000 | f000 | f000 | 1000 | f000 | fggg | ||||
| A | M A Device | 20 | 19 | ||||||||
| S IVCooke | 16 | 13 | |||||||||
| Dr1Bernstein | |||||||||||
| Mr N Gibbon | 41 | 42 | |||||||||
| Others | (I) | ||||||||||
| Total | 0 | 0 | 0 | (I) | 79 | ||||||
| Details of | IE2 | Name offund | Description of | the nature | and purpose of | each fund | |||||
| material | A | MA Device | Bed endowment | fund for Patients | Welfare | ||||||
| funds- | SI V Cooke | Holiday fund for Nurses |
|||||||||
| Endowment | Dr J Bernstein | RLUH Convalescence and recreation fund |
|||||||||
| Funds 31.03.21 | D | Mr N Gibbon | Annual Urology |
Scholatship | |||||||
| 12.3 | Endowment | Funds 31.03.20 | Balance 31 March 2019 |
Incoming Resources |
Resources Expended |
Gains snd Losses |
Balance 31 March 2020 |
||||
| gist | individually) | 2000 | f000 | f000 | f000 | f000 | f000 | ||||
| A | M A Device | 20 | 20 | ||||||||
| B | S IV Cooke | 16 | 16 | ||||||||
| C | DrJBernstein | ||||||||||
| D | Mr N Gibbon | 42 | 41 | ||||||||
| Others | (I) | ||||||||||
| Total | 81 | 0 | 0 | 0 | (I) | 00 | |||||
| Details of | 12.4 | Name offund | Description of | the nature | and purpose of | each fund | |||||
| material | M A Device | Bed endowment | fund for Patients | Welfare | |||||||
| funds- | S IV Cooke | Holiday fund for Nurses |
|||||||||
| Endowment | Dr J Bernstein | RLUH Convalescence and |
recreation fund |
||||||||
| Funds 31.03.20 | D | Mr N Gibbon | Annual Urology |
Scholarship |
| Analysis of Funds |
12 | cont'd | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.5 | Restricted | Funds | 31.03.21 | Balance 31 March 2020 |
Incoming Resources |
Resources Expended |
Transfers | Gains and Losses |
Balance 31 March 2021 |
|||||||||
| 6000 | 5000 | 5000 | (000 | 5000 | 5000 | |||||||||||||
| Maierialfunds | ||||||||||||||||||
| (hst mdividuagy) | ||||||||||||||||||
| Endocrinology | Fund | 703 | 23 | (17) | 156 | 865 | ||||||||||||
| RLUH General | Purpose | 511 | 286 | (241) | 252 | 808 | ||||||||||||
| L'pool Reg Dialysis | Fund | 662 | 24 | (102) | 163 | 747 | ||||||||||||
| RLBUHT General Purpose | 231 | 1,020 | (723) | 54 | 582 | |||||||||||||
| RLUH Patient | Welfare | Fund | 399 | 35 | (3) | 59 | 490 | |||||||||||
| Forget Me Not | Fund | 475 | 24 | (124) | 100 | 475 | ||||||||||||
| G | BGH Haematology | Fund | 346 | 13 | (8) | 76 | 427 | |||||||||||
| RLUH Renal Transplant | Fund | 266 | (6) | 59 | 328 | |||||||||||||
| Others(98) | 2,792 | 259 | (319) | 795 | 3,527 | |||||||||||||
| Total | 6,385 | 1,693 | (1,543) | 0 | 1,714 | 8,249 | ||||||||||||
| Details of | 12.6 | Name of fund | Description ofihe nature and | purpose ofeach | fund | |||||||||||||
| material | Endocrinology | Fund | Any chantable | purpose relating |
to disease | ofthe gland | ||||||||||||
| funds- | RLUH General | Purpose | Any charilable | purpose relating |
to Royal Liverpool | University | Hospital | |||||||||||
| Restricted | L'pool Reg Dialysis | Fund | Any chantable | purpose rais tmg |
to Dialysu | services | ||||||||||||
| Funds 31.03.21 | RLBUHT General Purpose |
Any charilable | purpose relatmg |
to Royal Liverpool | & Broadgreen | University | Hospitals | |||||||||||
| RLUH Patients | Welfare | Fund | For the rehef ofRLUH patients | suffering | from sickness and disease or its effects | |||||||||||||
| Forget Me Not | Fund | Any charitable | purpose relating |
to cancer | services | |||||||||||||
| BGH Haematology | Fund | Any charilable | purposes relating |
to Haemalology | Unit | |||||||||||||
| RLUH Renal Transplant | Fund | Any chanlable | purpose relating |
to Renal Transplant | Unit | |||||||||||||
| 12.7 | Restricted | Funds | 31.03.20 | Balance 31 March 2019 |
Incoming Resources |
Resources Expended |
Transfers | Gains and Losses |
Balance 31 March 2020 |
|||||||||
| 6000 | f000 | 5000 | f000 | 5000 | 5000 | |||||||||||||
| Material | funds | |||||||||||||||||
| (list individually) | ||||||||||||||||||
| Endocrinology | Fund | 1,272 | 35 | (20) | (500) | (84) | 703 | |||||||||||
| RLUH General | Purpose | 583 | 466 | (848) | 500 | (190) | 511 | |||||||||||
| L*pool Reg Dialysis | Fund | 875 | 30 | (121) | (122) | 662 | ||||||||||||
| RLBUHT General Purpose |
19 | 261 | (2) | (47) | 231 | |||||||||||||
| RLUH Patient | Welfare | Fund | 413 | (19) | 399 | |||||||||||||
| Forget Me Not | Fund | 670 | 1,386 | (1,540) | (41) | 475 | ||||||||||||
| BGH Haematology | Fund | 392 | 13 | P) | (52) | 346 | ||||||||||||
| RLUH Renal Transplant | Fund | 303 | (6) | (40) | 266 | |||||||||||||
| Others (98) | 3,910 | 529 | (1,073) | (574) | 2,792 | |||||||||||||
| Total | 8,437 | 2,734 | (3,636) | 0 | (1,150) | 6,385 | ||||||||||||
| Details of | 12.8 | Name offund | Description ofthe nature and | purpose ofeach | fund | |||||||||||||
| material | Endocrinology | Fund | Any charitable | purpose relating |
to disease | ofthe gland | ||||||||||||
| funds- | RLUH General | Purpose | Any charitable | purpose relating |
lo Royal Liverpool | University | Hospital | |||||||||||
| Restricted | L*pool Reg Dialysis | Fund | Any charitable | purpose relating |
lo Dialysis services | |||||||||||||
| Funds 31.03.20 | RLBUHT General Purpose | Any charitable | purpose relating |
lo Royal Liverpool | & Broadgreen | University | Hospitals | |||||||||||
| RLUH Patients | Welfare | Fund | For the relief of RLUH patients | suffenng | from sickness and disease or its effects | |||||||||||||
| Forget Me Not | Fund | Any charitable | purpose relating |
lo cancer | services | |||||||||||||
| BGH Haematology | Fund | Any charitable | purposes relaltng |
lo Haemalology | Unit | |||||||||||||
| RLUH Renal Tmnsplant | Fund | Any charitable | purpose relating |
lo Renal Transplant | Unit |
| Contingencies | 13 | There were no contingent assets |
or liabilities | or liabilities | for the charity included | for the charity included | for the charity included | in | the accounts: | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Commitments, | 14.1 | The Charity has no commitments, | liabilities | or provisions. | |||||||
| Liabliities and | |||||||||||
| Provisions | |||||||||||
| 14.2 | The Trustee recognise ltabtlities | tn the accounts once they have | incurred | either a | |||||||
| legal or constructive obligation |
to | expend funds. | |||||||||
| Trustee and | 15 | ||||||||||
| Connected | |||||||||||
| Persons | 15.1 | Trustee expenses reimbursed | 2020-21 | 20I9-20 | |||||||
| Transactions | f. | ||||||||||
| Travel snd subsistence | 0 | ||||||||||
| Entertainment | |||||||||||
| Other (please describe) | |||||||||||
| Total number of Trust Board Members representing | the Trustee | ||||||||||
| 15.2 | There was no Trustee remuneration | ||||||||||
| 15.3 | There were no transactions with |
a | Trustee or connected persons | in any | |||||||
| personal capacity |
|||||||||||
| 15.4 | Trustee Indemnity Insurance |
||||||||||
| Cover provided under Liverpool |
University | Hospitals | NHS Foundation | Trust's | |||||||
| Litigation Authority Non-clinical |
risk scheme. |
| Name, nature ofconnection, | Name, nature ofconnection, | 2020-21 | 2020-21 | 2019-20 | 2019-20 | ||||
|---|---|---|---|---|---|---|---|---|---|
| description ofactivities undertaken | Turnover | of | Net Profit/ | Turnover | of | Net | Profit/ | ||
| and details ofany qualifications | Connected | (Loss) for the | Connected | Loss | for the | ||||
| expressed | by their auditors | Organisation | Connected | Organisation | Connected | ||||
| Organisation | Organisation | ||||||||
| f | f | ||||||||
| Liverpool | University Hospitals |
NHS FT | |||||||
| (formerly | Royal Liverpool R Broadgreen | 1,109,384,000 | 1,410,000 | 693,482,000 | 283,159,000 | ||||
| University | Hospitals NHS Trust) |